Regulatory challenges and considerations for the clinical application of CAR-T cell anti-cancer therapy

Frederick L. LockeDepartment of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA;Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, FL, USACorrespondence[email protected]
View further author information

Marco L. DavilaDepartment of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA;Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, FL, USACorrespondence[email protected]
View further author information

Click to increase image sizeClick to decrease image size

Declaration of interest

F Locke is on the advisory board of Kite Pharma and is a consultant for Cellular Biomedicine Group Inc. (CBMG). M Davila is on the advisory board of Celyad, Precision Bioscience and Servier. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Additional information

Funding

This manuscript has not been funded.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Regulatory challenges and considerations for the clinical application of CAR-T cell anti-cancer therapy

Information for

Open access

Opportunities

Help and information

Regulatory challenges and considerations for the clinical application of CAR-T cell anti-cancer therapy

Declaration of interest

Additional information

Funding

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature